INNPF
InnoCan Pharma Corporation, a pharmaceutical company, focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in the United States, Poland, France, and internationally. The company engages in the research and development of COVID-19 and other condition treatment by using CBD loaded exosomes; and CBD loaded liposomes. Its product includes CBD eye serum, CBD face oil, CBD face cream, CBD facial serum, CBD sleeping mask, CBD recovery lotion, and the Relief & Go spray. The company is also involved in the commercialization and sale of branded CBD integrated pharmaceutical and topical treatment products. InnoCan Pharma Corporation was incorporated in 2018 and is headquartered in Calgary, Canada.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q1 | -0.21 | $6M | -$498,987 |
| 2025 Q4 | 0.44 | $5M | -$587,000 |
| 2025 Q3 | -0.43 | $7M | $18,000 |
| 2025 Q2 | -0.13 | $7M | $685,000 |
| 2025 Q1 | -0.13 | $8M | $363,000 |
| 2024 Q4 | -0.03 | $5M | -$508,000 |
| 2024 Q3 | -0.07 | $9M | -$1M |
| 2024 Q2 | 0.08 | $9M | $672,000 |